| ViewpointEquipping Dermatologists to Address Structural and Social Drivers of Inequities—Structural Competency Cruz Riley, BA; Rebecca Vasquez, MD; Ellen N. Pritchett, MD, MPH EditorialExtending Maintenance Dosing Intervals for Guselkumab in the Treatment of Patients With Psoriasis Andrew Blauvelt, MD, MBA; Curdin Conrad, MD; Megan H. Noe, MD, MPH, MSCE Original InvestigationNoninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis: The GUIDE Randomized Clinical Trial Kilian Eyerich, MD; Khusru Asadullah, MD; Andreas Pinter, MD; et al.Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata Arash Mostaghimi, MD, MPA, MPH; Ahmed M. Soliman, PhD; Chao Li, PhD; et al. Images in DermatologyPrimary Cutaneous Cryptococcosis Ying-Hsiang Wang, MD; Jui Lan, MD; Shang-Hung Lin, MD, PhD Earn CME credit Research LetterUpadacitinib for Treatment of Granulomatous Cheilitis Axel De Greef, MD; Caroline Peeters, MD; Olivier Dewit, MD, PhD; et al. |